The FDA has approved an expanded indication for the Infinity™ Deep Brain Stimulation (DBS) system (Abbott) to include targeting the internal globus pallidus, which may lead to symptom improvement in ...

Abbott’s Infinity Deep Brain Stimulation (DBS) system has received an expanded clearance from the FDA that now permits the targeted stimulation of a new area of the brain associated with Parkinson’s ...

Abbott’s Subhan Khan, vice president of neuromodulation development, said one of the biggest engineering challenges with the company’s Infinity Deep Brain Stimulation System was figuring out how to ...